Radiofrequency ablation of colorectal liver metastases

Czech version

Authors: V. Třeška ¹; J. Brůha ¹; T. Skalický ¹; V. Liška ¹; J. Fichtl ¹; H. Mírka ²; E. Korčáková ²
Authors‘ workplace: Chirurgická klinika Fakultní nemocnice Plzeň, Lékařská fakulta v Plzni, Univerzita Karlova ¹; Klinika zobrazovacích metod, Fakultní nemocnice Plzeň, Lékařská fakulta v Plzni, Univerzita Karlova ²
Published in: Rozhl. Chir., 2019, roč. 98, č. 10, s. 399-403.
Category: Original articles

Overview

Introduction: Radical liver resection is the only method for the treatment of patients with colorectal liver metastases (CLM); however, only 20–30% of patients with CLMs can be radically treated. Radiofrequency ablation (RFA) is one of the possible methods of palliative treatment in such patients.

Methods: RFA was performed in 381 patients with CLMs between 01 Jan 2001 and 31 Dec 2018. The mean age of the patients was 65.2±8.7 years. The male to female ratio was 2:1. Open laparotomy was done in 238 (62.5%) patients and the CT-navigated transcutaneous approach was used in 143 (37.5%) patients. CLMs <5 cm (usually <3 cm) in diameter were the indication for RFA. We used RFA as the only method in 334 (87.6%) patients; RFA in combination with resection was used in 36 (9.4%), and with multi-stage resection in 11 (3%) patients. We performed RFA in a solitary CLM in 170 (44.6%) patients, and in 2−5 CLMs in 211 (55.6%) patients. We performed computed tomography in each patient 48 hours after procedure.

Results: The 30-day postoperative mortality was zero. Complications were present in 4.8% of transcutaneous and in 14.2% of open procedures, respectively, in the 30-day postoperative period. One-, 3-, 5- and 10-year overall survival rates were 94.8, 66.8, 43.9 and 16.6%, respectively, in patients undergoing RFA, and 90.6, 69.1, 52.8 and 39.2%, respectively, in patients with liver resections. Disease free survival was 63.2, 30.1, 18.4 and 13.1%, respectively, in the same patients after RFA, and 71.1, 33.3, 22.8 and 15.5%, respectively, after liver resections.

Conclusion: RFA is a palliative thermal ablation method, which is one of therapeutic options in patients with radically non-resectable CLMs. RFA is useful especially in a non-resectable, or resectable (but for the price of large liver resection) solitary CLM <3 cm in diameter and in CLM relapses. RFA is also part of multi-stage liver procedures.

Keywords:

long-term results – colorectal liver metastases – radiofrequency ablation

Sources

Grundmann RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg. 2011;3:183−96. doi: 10.4240/wjgs.v3.i12.183.
Chow FC, Chok KS. Colorectal liver metastases: An update on multidisciplinary approach. World J Hepatol. 2019;11:150−72. doi: 10.4254/wjh.v11.i2.150.
Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3:50−6. doi: 10.1002/ags3.12227.
Viganò L, Pedicini V, Comito T, et al. Aggressive and multidisciplinary local approach to iterative recurrences of colorectal liver metastases. World J Surg. 2018;42:2651−9. doi: 10.1007/s00268-018-4525-x.
Petre EN, Sofocleous C. Thermal ablation in the management of colorectal cancer patients with oligometastatic liver disease. Visc Med. 2017;33:62−8. doi: 10.1159/000454697.
Elias D, Viganò L, Orsi F, et al. New perspectives in the treatment of colorectal metastases. Liver Cancer 2016;6:90−8. doi: 10.1159/000449492.
Benhaim L, El Hajjam M, Malafosse R, et al. Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression. HPB (Oxford) 2018;20:76−82. doi: 10.1016/j.hpb.2017.08.023.
Vavra P, Nowakova J, Ostruszka P. Colorectal cancer liver metastases: laparoscopic and open radiofrequency-assisted surgery. Wideochir Inne Tech Maloinwazyjne. 2015;10:205−12. doi: 10.5114/wiitm.2015.52082.
van Amerongen MJ, Jenniskens SFM, van den Boezem PB. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases – a meta-analysis. HPB (Oxford) 2017;19:749−56. doi: 10.1016/j.hpb.2017.05.011.
Shady W, Petre EN, Do KG. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: Ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29:268−75. doi: 10.1016/j.jvir.2017.08.021.
Lee BC, Lee HG, Park IJ. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) 2016;95:e4999. doi: 10.1097/MD.0000000000004999.
Dervenis C, Xynos E, Sotiropoulos G, et al. Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol. 2016;29:390−416. doi 10.20524/aog.2016.0050.
Hof J, Joosten HJ, Havenga K, et al. Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer. PLoS One. 2018;13:e0193385. doi: 10.1371/journal.pone.0193385.
Brůha J, Liška V, Pálek R, et al. Porovnání perkutánního a otevřeného přístupu RFA u jaterních metastáz kolorektálního karcinomu. Rozhl Chir 2016;95:107−11.
Třeška V, Skalický T, Ferda J, et al. Chirurgie jaterních metastáz kolorektálního karcinomu – přítomnost a budoucnost. Rozhl Chir 2014;93:568−71.
Shady W, Petre EN, Vakiani E, et al. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases. Oncotarget. 2017;8:66117−27. doi.org/10.18632/oncotarget.19806.
Ruers T, Van Coevorden F, Punt CJ, et al. Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. J Natl Cancer Inst. 2017;109. doi: 10.1093/jnci/djx015.
Yamakado K, Inaba Y, Sato Y, et al. Radiofrequency ablation combined with hepatic arterial chemoembolization using degradable starch microsphere mixed with mitomycin C for the treatment of liver metastasis from colorectal cancer: A prospective multicenter study. Cardiovasc Intervent Radiol. 2017;40:560−7. doi: 10.1007/s00270-016-1547-3.
Sasaki K, Margonis GA, Andreatos N,et al. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes. J Surg Res. 2016;206:182−9. doi: 10.1016/j.jss.2016.06.098.
Chen Q, Li C, Yang H, Zhao H, et al. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China. Clin Res Hepatol Gastroenterol. 2018; 18: 30228−6. doi: 10.1097/MCG.0000000000000008.
Puijk RS, Ruarus AH, Vroomen LGPH, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial. BMC Cancer 2018;18:821. doi: 10.1186/s12885-018-4716-8.
Vogl TJ, Farshid P, Naguib NN, et al. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging. 2015;40:1829−37. doi: 10.1007/s00261-015-0355-6.
Long L, Wei L, Hong W. Meta-analysis of long-term outcomes in patients with colorectal liver metastases undergoing hepatectomy with or without radiofrequency blation. Am Surg. 2018;84:1913−23.

Labels

Surgery Orthopaedics Trauma surgery

Repopulation of decellularized pig scaffolds: Promising approach for liver tissue engineering

Synchronous liver metastases of rectal cancer and the possibility of simultaneous resection

Jaterní chirurgie 21. století

Therapy of liver cysts – experience of the Department of Surgery, University Hospital in Pilsen 2009−2018

Comparison of surgical intervention to Cyberknife® radiotherapy in the treatment of liver malignancies

Multidisciplinary team in colorectal cancer treatment – analysis of our patients in 2017

Endovascular treatment of aorto-hepatic bypass thrombosis following liver transplantation

Zemřel primář Otomar Rychnovský

Odcházení

Article was published in

Perspectives in Surgery

2019 Issue 10